Athletes may have illnesses or conditions that require them to take particular medications. If the medication an athlete is required to take to treat an illness or condition happens to fall under the Prohibited List, a Therapeutic Use Exemption (TUE) may give that athlete the authorization to take the needed medicine.
The ISSF has its own TUE Committee that considers all submitted TUE applications and that grants or denies TUEs to international-level athletes in shooting sport. All athletes intending to compete at the international-level must apply for and obtain a TUE from ISSF. The application must always be submitted at least 30 days before competing.
The criteria for granting a TUE are:
a. The Prohibited Substance or Prohibited Method in question is needed to treat an acute or chronic medical condition, such that the athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld.
b. The therapeutic use of the Prohibited Substance or Prohibited Method is highly unlikely to produce any additional enhancement of performance beyond what might be anticipated by a return to the Athlete’s normal state of health following the treatment of the acute or chronic medical condition.
c. There is no reasonable therapeutic alternative to the Use of the Prohibited Substance or Prohibited Method.
d. The necessity for the use of the Prohibited Substance or Prohibited Method is not a consequence, wholly or in part, of the prior use (without a TUE) of a substance or method which was prohibited at the time of such use.
Any national-level shooter holding a national-level TUE must inform ISSF of the TUE and request ISSF recognition of the TUE prior to competing in any international competition, failing which the national level TUE will be deemed to be non-valid at the international level. Should the ISSF TUEC decide to not recognize the national-TUE it will also be invalid for international competition.
Please see article 4.4 of the ISSF Anti-Doping Rules which deals with Therapeutic Use Exemptions.